Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats

Hypertension

Volumn 40, Issue 2, 2002, Pages 190-194

  Nishimoto, Yasuhiro ^a   Tomida, Takahito ^a   Matsui, Hideo ^a   Ito, Takayuki ^a   Okumura, Kenji ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fructose; Hypertension, sodium dependent; Insulin resistance; Kidney; Nitric oxide synthase

Indexed keywords

FRUCTOSE; NITRIC OXIDE SYNTHASE; PIOGLITAZONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; HYPERTENSION; INSULIN RESISTANCE; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM LOAD; SODIUM RESTRICTION; URINALYSIS; WESTERN BLOTTING;

ANIMALS; AORTA; BLOOD PRESSURE; DIETARY SUCROSE; FRUCTOSE; HYPERTENSION; HYPOGLYCEMIC AGENTS; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SODIUM CHLORIDE, DIETARY; THIAZOLES; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036324466     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000024267.71656.0D     Document Type: Article

References (48)

1. Insulin resistance in essential hypertension
2. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
3. Subpressor dose of L-NAME unmasks hypertensive effect of chronic hyperinsulinemia
4. - imbalance in insulin-resistant rat aorta
5. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin
6. The renal medulla and hypertension
7. Evolution of chronic nitric oxide inhibition hypertension: Relationship to renal function
8. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney
9. Role of NO on pressure-natriuresis in Wistar-Kyoto and spontaneously hypertensive rats
10. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis
11. NaCl sensitivity of essential hypertensive patients is related to insulin resistance
12. Blood pressure, sodium intake, insulin resistance, and urinary nitrate excertion
13. Altered pressure-natriuresis in obese Zucker rats
14. Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity
15. Nitric oxide: A physiologic messenger molecule
16. Isoforms of nitric oxide synthase: Characterization and purification from different cell types
17. eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux
18. Improved insulin sensitivity by bezafibrate in rats: Relationship to fatty acid composition of skeletal-muscle triglycerides
19. Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats
20. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration
21. L-Arginine treatment may prevent tubulointerstitial nephropathy caused by germanium dioxide
22. Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats
23. Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats
24. Increased vascular endothelin-I gene expression with unaltered nitric oxide synthase levels in fructose-induced hypertensive rats
25. Fructose feeding in rats is not associated with sodium retention
26. Pressure-volume regulation in hypertension
27. Nitric oxide dependency of arterial pressure-induced changes in renal interstitial hydrostatic pressure in dogs
28. Influence of dietary sodium intake on renal medullary nitric oxide synthase
29. Nitric oxide in the renal medulla protects from vasopressin-induced hypertension
30. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats
31. Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression
32. Salt-sensitive hypertension develops after short-term exposure to angiotensin II
33. Evidence that reduced renal medullary nitric oxide synthase activity of Dahl S rats enables small elevations of arginine vasopressin to produce sustained hypertension
34. Decreased renal expression of nitric oxide synthase isoforms in adrenocorticotropin-induced and corticosterone-induced hypertension
35. Endothelial nitric oxide synthase protein is reduced in the renal medulla of two-kidney, one-clip hypertensive rats
36. Effect of salt loading on nitric oxide synthase expression in normotensive rats
37. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression
38. Mechanism of impaired nitric oxide synthase activity in skeletal muscle of streptozotocin-induced diabetic rats
39. TNF-α inhibits flow and insulin signaling leading to NO production in aortic endothelial cells
40. Shear stress-mediated NO production in inner medullary collecting duct cells
41. A high fructose diet affects the early steps of insulin action in muscle and liver of rats
42. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance
43. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
44. The contribution of skeletal muscle tumor necrosis factor-α to insulin resistance and hypertension in fructose-fed rats
45. Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ
46. Pioglitazone time-dependently reduces tumour necrosis factor-α level in muscle and improves metabolic abnormalities in Wistar fatty rats
47. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
48. Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney